Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Sensors (Basel) ; 24(4)2024 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-38400471

RESUMO

Addressing inherent limitations in distinguishing metrics relying solely on Euclidean distance, especially within the context of geo-indistinguishability (Geo-I) as a protection mechanism for location-based service (LBS) privacy, this paper introduces an innovative and comprehensive metric. Our proposed metric not only incorporates geographical information but also integrates semantic, temporal, and query data, serving as a powerful tool to foster semantic diversity, ensure high servifice similarity, and promote spatial dispersion. We extensively evaluate our technique by constructing a comprehensive metric for Dongcheng District, Beijing, using road network data obtained through the OSMNX package and semantic and temporal information acquired through Gaode Map. This holistic approach proves highly effective in mitigating adversarial attacks based on background knowledge. Compared with existing methods, our proposed protection mechanism showcases a minimum 50% reduction in service quality and an increase of at least 0.3 times in adversarial attack error using a real-world dataset from Geolife. The simulation results underscore the efficacy of our protection mechanism in significantly enhancing user privacy compared to existing methodologies in the LBS location privacy-protection framework. This adjustment more fully reflects the authors' preference while maintaining clarity about the role of Geo-I as a protection mechanism within the broader framework of LBS location privacy protection.

2.
Nano Lett ; 23(3): 757-764, 2023 02 08.
Artigo em Inglês | MEDLINE | ID: mdl-36648291

RESUMO

Effective delivery of the CRISPR-Cas9 components is crucial to realizing the therapeutic potential. Although many delivery approaches have been developed for this application, oral delivery has not been explored due to the degradative nature of the gastrointestinal tract. For this issue, we developed a series of novel phenylboronic acid (PBA)-functionalized chitosan-polyethylenimine (CS-PEI) polymers for oral CRISPR delivery. PBA functionalization equipped the polyplex with higher stability, smooth transport across the mucus, and efficient endosomal escape and cytosolic unpackaging in the cells. From a library of 12 PBA-functionalized CS-PEI polyplexes, we identified a formulation that showed the most effective penetration in the intestinal mucosa after oral gavage to mice. The optimized formulation performed feasible CRISPR-mediated downregulation of the target protein and reduction in the downstream cholesterol. As the first oral CRISPR carrier, this study suggests the potential of addressing the needs of both local and systemic editing in a patient-compliant manner.


Assuntos
Ácidos Borônicos , Quitosana , Animais , Camundongos , Polímeros , Técnicas de Transferência de Genes
3.
Small ; 19(41): e2300380, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37340576

RESUMO

Despite the promising achievements of immune checkpoint blockade (ICB) therapy for tumor treatment, its therapeutic effect against solid tumors is limited due to the suppressed tumor immune microenvironment (TIME). Herein, a series of polyethyleneimine (Mw = 0.8k, PEI0.8k )-covered MoS2 nanosheets with different sizes and charge densities are synthesized, and the CpG, a toll-like receptor-9 agonist, is enveloped to construct nanoplatforms for the treatment of head and neck squamous cell carcinoma (HNSCC). It is proved that functionalized nanosheets with medium size display similar CpG loading capacity regardless of low or high PEI0.8k coverage owing to the flexibility and crimpability of 2D backbone. CpG-loaded nanosheets with medium size and low charge density (CpG@MM -PL ) could promote the maturation, antigen-presenting capacity, and proinflammatory cytokines generation of bone marrow-derived dendritic cells (DCs). Further analysis reveals that CpG@MM -PL effectively boosts the TIME of HNSCC in vivo including DC maturation and cytotoxic T lymphocyte infiltration. Most importantly, the combination of CpG@MM -PL and ICB agents anti-programmed death 1 hugely improves the tumor therapeutic effect, inspiring more attempts for cancer immunotherapy. In addition, this work uncovers a pivotal feature of the 2D sheet-like materials in nanomedicine development, which should be considered for the design of future nanosheet-based therapeutic nanoplatforms.


Assuntos
Neoplasias de Cabeça e Pescoço , Humanos , Carcinoma de Células Escamosas de Cabeça e Pescoço/tratamento farmacológico , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Molibdênio , Imunoterapia , Citocinas , Microambiente Tumoral
4.
Water Sci Technol ; 78(1-2): 310-319, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30101766

RESUMO

Chemical oxygen demand (COD), an important indicative measure of the amount of oxidizable pollutants in wastewater, is often analyzed off-line due to the expensive sensor required for on-line analysis. However, its off-line analysis is time-consuming. An on-line COD estimation method was developed with photoelectrocatalytic (PEC) technology. Based on the on-line data of the oxidation-reduction potential (ORP), dissolved oxygen (DO) and pH of wastewater, four different artificial neural network methods were applied to develop working models for COD estimation. Six different batches of sequence batch reactor (SBR) effluent from a paper mill were treated with PEC oxidation for 90 minutes, and 546 data points were collected from the on-line measurements of ORP, DO and pH, and the off-line COD analysis. After having training and validation with 75% and 25% of data, and evaluation with four statistical criteria (R2, RMSE, MAE and MAPE), the estimation results indicated that the developed radial basis neural network (RBNN) model demonstrated the highest precision. Subsequently, the application of the RBNN model to a new batch of SBR effluent from the paper mill revealed that the RBNN model was acceptable for COD estimation during the PEC advanced treatment process of papermaking wastewater, which implied its possible application in the future.


Assuntos
Análise da Demanda Biológica de Oxigênio , Resíduos Industriais/análise , Eliminação de Resíduos Líquidos/métodos , Águas Residuárias/química , Oxirredução , Papel
5.
Acta Biomater ; 174: 314-330, 2024 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-38036284

RESUMO

Epilepsy refers to a disabling neurological disorder featured by the long-term and unpredictable occurrence of seizures owing to abnormal excessive neuronal electrical activity and is closely linked to unresolved inflammation, oxidative stress, and hypoxia. The difficulty of accurate localization and targeted drug delivery to the lesion hinders the effective treatment of this disease. The locally activated inflammatory cells in the epileptogenic region offer a new opportunity for drug delivery to the lesion. In this work, CD163-positive macrophages in the epileptogenic region were first harnessed as Trojan horses after being hijacked by targeted albumin manganese dioxide nanoparticles, which effectively penetrated the brain endothelial barrier and delivered multifunctional nanomedicines to the epileptic foci. Hence, accumulative nanoparticles empowered the visualization of the epileptogenic lesion through microenvironment-responsive MR T1-weight imaging of manganese dioxide. Besides, these manganese-based nanomaterials played a pivotal role in shielding neurons from cell apoptosis mediated by oxidative stress and hypoxia. Taken together, the present study provides an up-to-date approach for integrated diagnosis and treatment of epilepsy and other hypoxia-associated inflammatory diseases. STATEMENT OF SIGNIFICANCE: The therapeutic effects of antiepileptic drugs (AEDs) are hindered by insufficient drug accumulation in the epileptic site. Herein, we report an efficient strategy to use locally activated macrophages as carriers to deliver multifunctional nanoparticles to the brain lesion. As MR-responsive T1 contrast agents, multifunctional BMC nanoparticles can be harnessed to accurately localize the epileptogenic region with high sensitivity and specificity. Meanwhile, catalytic nanoparticles BMC can synergistically scavenge ROS, generate O2 and regulate neuroinflammation for the protection of neurons in the brain.


Assuntos
Epilepsia , Nanopartículas , Humanos , Nanomedicina Teranóstica , Epilepsia/tratamento farmacológico , Macrófagos , Hipóxia , Nanopartículas/uso terapêutico
6.
Adv Sci (Weinh) ; 11(1): e2305273, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37997512

RESUMO

Trauma and its associated complications, including dysregulated inflammatory responses, severe infection, and disseminated intravascular coagulation (DIC), continue to pose lethal threats worldwide. Following injury, cell-free nucleic acids (cfNAs), categorized as damage-associated molecular patterns (DAMPs), are released from dying or dead cells, triggering local and systemic inflammatory responses and coagulation abnormalities that worsen disease progression. Harnessing cfNA scavenging strategies with biomaterials has emerged as a promising approach for treating posttrauma systemic inflammation. In this study, the effectiveness of cationic hyperbranched polyaminoglycosides derived from tobramycin (HPT) and disulfide-included HPT (ss-HPT) in scavenging cfNAs to mitigate posttrauma inflammation and hypercoagulation is investigated. Both cationic polymers demonstrate the ability to suppress DAMP-induced toll-like receptor (TLR) activation, inflammatory cytokine secretion, and hypercoagulation by efficiently scavenging cfNAs. Additionally, HPT and ss-HPT exhibit potent antibacterial efficacy attributed to the presence of tobramycin in their chemical composition. Furthermore, HPT and ss-HPT exhibit favorable modulatory effects on inflammation and therapeutic outcomes in a cecal ligation puncture (CLP) mouse abdominal trauma model. Notably, in vivo studies reveal that ss-HPT displayed high accumulation and retention in injured organs of traumatized mice while maintaining a higher biodegradation rate in healthy mice, contrasting with findings for HPT. Thus, functionalized ss-HPT, a bioreducible polyaminoglycoside, holds promise as an effective option to enhance therapeutic outcomes for trauma patients by alleviating posttrauma inflammation and coagulation complications.


Assuntos
Coagulação Sanguínea , Inflamação , Humanos , Camundongos , Animais , Modelos Animais de Doenças , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Tobramicina/farmacologia , Tobramicina/uso terapêutico
7.
ACS Nano ; 18(9): 7084-7097, 2024 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-38377352

RESUMO

Severe airway inflammatory disorders impose a significant societal burden, and the available treatments are unsatisfactory. High levels of neutrophil extracellular trap (NET) and cell-free DNA (cfDNA) were detected in the inflammatory microenvironment of these diseases, which are closely associated with persistent uncontrolled neutrophilic inflammation. Although DNase has proven to be effective in mitigating neutrophilic airway inflammation in mice by reducing cfDNA and NET levels, its clinical use is hindered by severe side effects. Here, we synthesized polyglycerol-amine (PGA) with a series of hydroxyl/amine ratios and covered them with black phosphorus (BP) nanosheets. The BP nanosheets functionalized with polyglycerol-50% amine (BP-PGA50) efficiently lowered cfDNA levels, suppressed toll-like receptor 9 (TLR9) activation and inhibited NET formation in vitro. Importantly, BP-PGA50 nanosheets demonstrated substantial accumulation in inflamed airway tissues, excellent biocompatibility, and potent inflammation modulation ability in model mice. The 2D sheet-like structure of BP-PGA50 was identified as a crucial factor for the therapeutic efficacy, and the hydroxyl/amine ratio was revealed as a significant parameter to regulate the protein resistance, cfDNA-binding efficacy, and cytotoxicity. This study shows the promise of the BP-PGA50 nanosheet for tackling uncontrolled airway inflammation, which is also significant for the treatment of other neutrophilic inflammatory diseases. In addition, our work also highlights the importance of proper surface functionalization, such as hydroxyl/amine ratio, in therapeutic nanoplatform construction for inflammation modulation.


Assuntos
Ácidos Nucleicos Livres , Glicerol , Neutrófilos , Polímeros , Camundongos , Animais , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Aminas/farmacologia
8.
bioRxiv ; 2024 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-38328122

RESUMO

Vascular malformation, a key clinical phenotype of Proteus syndrome, lacks effective models for pathophysiological study and drug development due to limited patient sample access. To bridge this gap, we built a human vascular organoid model replicating Proteus syndrome's vasculature. Using CRISPR/Cas9 genome editing and gene overexpression, we created induced pluripotent stem cells (iPSCs) embodying the Proteus syndrome-specific AKTE17K point mutation for organoid generation. Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections. This could be due to the significant vasculogenesis induced by AKT overactivation. This phenomenon likely stems from boosted vasculogenesis triggered by AKT overactivation, leading to increased vascular sprouting. Additionally, a notable increase in dysfunctional PDGFRß+ mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids. The application of AKT inhibitors (ARQ092, AZD5363, or GDC0068) reversed the vascular malformations; the inhibitors' effectiveness was directly linked to reduced connectivity in the organoids. In summary, our study introduces an innovative in vitro model combining organoid technology and gene editing to explore vascular pathophysiology in Proteus syndrome. This model not only simulates Proteus syndrome vasculature but also holds potential for mimicking vasculatures of other genetically driven diseases. It represents an advance in drug development for rare diseases, historically plagued by slow progress.

9.
PLoS One ; 18(4): e0278138, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37043427

RESUMO

Directed greybox fuzzing guides fuzzers to explore specific objective code areas and has achieved good performance in some scenarios such as patch testing. However, if there are multiple objective code to explore, existing directed greybox fuzzers, such as AFLGo and Hawkeye, often neglect some targets because they use harmonic means of distance and prefers to test those targets with shorter reachable path. Besides, existing directed greybox fuzzers cannot calculate the accurate distance due to indirect calls in the program. In addition, existing directed greybox fuzzers fail to address the exploration and exploitation problem and have poor efficiency in seed scheduling. To address these problems, we propose a dynamic seed distance calculation scheme, it increase the seed distance dynamically when the reachable path encounter indirect call. Besides, the seed distance calculation can deal with the bias problem in multi-targets scenarios. With the seed distance calculation method, we propose a new seed scheduling algorithm based on the upper confidence bound algorithm to deal with the exploration and exploitation problem in drected greybox fuzzing. We implemented a prototype RLTG and evaluate it on real-world programs. Evaluation of our prototype shows that our approach outperforms a state-of-the-art directed fuzzer AFLGo. On the multi-targets benchmark Magma, RLTG reproduces bugs with 6.9x speedup and finds 66.7% more bugs than AFLGo.

10.
Pharmaceutics ; 16(1)2023 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-38276488

RESUMO

Conventionally, nanocarriers are used to regulate the controlled release of therapeutic payloads. Increasingly, they can also be designed to have an intrinsic therapeutic effect. For example, a positively charged nanocarrier can bind damage-associated molecular patterns, inhibiting toll-like receptor (TLR) pathway activation and thus modulating inflammation. These nucleic acid-binding nanomaterials (NABNs), which scavenge pro-inflammatory stimuli, exist in diverse forms, ranging from soluble polymers to nanoparticles and 2D nanosheets. Unlike conventional drugs that primarily address inflammation symptoms, these NABPs target the upstream inflammation initiation pathway by removing the agonists responsible for inflammation. Many NABNs have demonstrated effectiveness in murine models of inflammatory diseases. However, these scavengers have not been systematically studied and compared within a single setting. Herein, we screen a subset of the most potent NABNs to define their relative efficiency in scavenging cell-free nucleic acids and inhibiting various TLR pathways. This study helps interpret existing in vivo results and provides insights into the future design of anti-inflammatory nanocarriers.

11.
PLoS One ; 17(1): e0262176, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35073360

RESUMO

Transport layer security (TLS) protocol is the most widely used security protocol in modern network communications. However, protocol vulnerabilities caused by the design of the network protocol or its implementation by programmers emerge one after another. Meanwhile, various versions of TLS protocol implementations exhibit different behavioral characteristics. Researchers are attempting to find the differences in protocol implementations based on differential testing, which is conducive to discovering the vulnerabilities. This paper provides a solution to find the differences more efficiently by targeting the TLS protocol handshake process. The differences of different implementations during the fuzzing process, such as code coverage and response data, are taken to guide the mutation of test cases, and the seeds are mutated based on the TLS protocol syntax. In addition, the definition of duplicate discrepancies is theoretically explored to investigate the root cause of the discrepancies and to reduce the number of duplicate cases that are caused by the same reason. Besides, the necessary conditions for excluding duplicate cases are further analyzed to develop the deduplication strategy. The proposed method is developed based on open-source tools, i.e., NEZHA and TLS-diff. Three types of widely used TLS protocol implementations, i.e., OpenSSL, BoringSSL, and LibreSSL, are taken for experimental testing. The experimental results show that the proposed method can effectively improve the ability to find differences between different implementations. Under the same test scale or the same time, the amount of discrepancies increases by about 20% compared to TLS-diff, indicating the effectiveness of the deduplication strategy.


Assuntos
Segurança Computacional , Algoritmos , Lógica Fuzzy , Software
12.
Research (Wash D C) ; 2022: 9804014, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35958108

RESUMO

Tremendous progress has been made in the past decade regarding our understanding of the gut microbiome's role in human health. Currently, however, a comprehensive and focused review marrying the two distinct fields of gut microbiome and material research is lacking. To bridge the gap, the current paper discusses critical aspects of the rapidly emerging research topic of "material engineering in the gut microbiome and human health." By engaging scientists with diverse backgrounds in biomaterials, gut-microbiome axis, neuroscience, synthetic biology, tissue engineering, and biosensing in a dialogue, our goal is to accelerate the development of research tools for gut microbiome research and the development of therapeutics that target the gut microbiome. For this purpose, state-of-the-art knowledge is presented here on biomaterial technologies that facilitate the study, analysis, and manipulation of the gut microbiome, including intestinal organoids, gut-on-chip models, hydrogels for spatial mapping of gut microbiome compositions, microbiome biosensors, and oral bacteria delivery systems. In addition, a discussion is provided regarding the microbiome-gut-brain axis and the critical roles that biomaterials can play to investigate and regulate the axis. Lastly, perspectives are provided regarding future directions on how to develop and use novel biomaterials in gut microbiome research, as well as essential regulatory rules in clinical translation. In this way, we hope to inspire research into future biomaterial technologies to advance gut microbiome research and gut microbiome-based theragnostics.

13.
Acta Pharm Sin B ; 12(11): 4235-4248, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36386467

RESUMO

Anti-virulence strategy has been considered as one of the most promising approaches to combat drug-resistant bacterial infections. Pore-forming toxins (PFTs) are the largest class of bacterial toxins, inflicting their virulence effect through creating pores on the cell membrane. However, current solutions for eliminating PFTs are mostly designed based on their molecular structure, requiring customized design for different interactions. In the present study, we employed erythroliposome (denoted as RM-PL), a biomimetic platform constructed by artificial lipid membranes and natural erythrocyte membranes, to neutralize different hemolytic PFTs regardless of their molecular structure. When tested with model PFTs, including α-hemolysin, listeriolysin O, and streptolysin O, RM-PL could completely inhibit toxin-induced hemolysis in a concentration-dependent manner. In vivo studies further confirmed that RM-PL could efficiently neutralize various toxins and save animals' lives without causing damage to organs or tissues. In addition, we explored the underlying mechanisms of this efficient detoxification ability and found that it was mainly macrophages in the spleen and the liver that took up RM-PL-absorbed toxins through a variety of endocytosis pathways and digested them in lysosomes. In summary, the biomimetic RM-PL presented a promising system for broad-spectrum and powerful toxin neutralization with a mechanism of lysosome-mediated toxin degradation.

14.
Acta Pharm Sin B ; 12(8): 3427-3447, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35967283

RESUMO

Platelets buoy up cancer metastasis via arresting cancer cells, enhancing their adhesion, and facilitating their extravasation through the vasculature. When deprived of intracellular and granular contents, platelet decoys could prevent metastatic tumor formation. Inspired by these, we developed nanoplatesomes by fusing platelet membranes with lipid membranes (P-Lipo) to restrain metastatic tumor formation more efficiently. It was shown nanoplateletsomes bound with circulating tumor cells (CTC) efficiently, interfered with CTC arrest by vessel endothelial cells, CTC extravasation through endothelial layers, and epithelial-mesenchymal transition of tumor cells as nanodecoys. More importantly, in the mouse breast tumor metastasis model, nanoplateletsomes could decrease CTC survival in the blood and counteract metastatic tumor growth efficiently by inhibiting the inflammation and suppressing CTC escape. Therefore, nanoplatelesomes might usher in a new avenue to suppress lung metastasis.

15.
Acta Pharm Sin B ; 12(2): 967-981, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35256958

RESUMO

Tumor-targeted immunotherapy is a remarkable breakthrough, offering the inimitable advantage of specific tumoricidal effects with reduced immune-associated cytotoxicity. However, existing platforms suffer from low efficacy, inability to induce strong immunogenic cell death (ICD), and restrained capacity of transforming immune-deserted tumors into immune-cultivated ones. Here, an innovative platform, perfluorooctyl bromide (PFOB) nanoemulsions holding MnO2 nanoparticles (MBP), was developed to orchestrate cancer immunotherapy, serving as a theranostic nanoagent for MRI/CT dual-modality imaging and advanced ICD. By simultaneously depleting the GSH and eliciting the ICD effect via high-intensity focused ultrasound (HIFU) therapy, the MBP nanomedicine can regulate the tumor immune microenvironment by inducing maturation of dendritic cells (DCs) and facilitating the activation of CD8+ and CD4+ T cells. The synergistic GSH depletion and HIFU ablation also amplify the inhibition of tumor growth and lung metastasis. Together, these findings inaugurate a new strategy of tumor-targeted immunotherapy, realizing a novel therapeutics paradigm with great clinical significance.

16.
ACS Nano ; 16(12): 20430-20444, 2022 12 27.
Artigo em Inglês | MEDLINE | ID: mdl-36382718

RESUMO

Photothermal therapy (PTT) is an effective treatment modality that is highly selective for tumor suppression and is a hopeful alternative to traditional cancer therapy. However, PTT-induced inflammatory responses may result in undesirable side effects including increased risks of tumor recurrence and metastasis. Here we developed multifunctional MnO nanoparticles as scavengers of proinflammatory molecules to alleviate the PTT-induced inflammatory response. The MnO nanoparticles improve the PTT therapy by (1) binding and scavenging proinflammatory molecules to inhibit the proinflammatory molecule-induced Toll-like receptors (TLR) activation and nuclear factor kappa B (NF-κB) signaling; (2) inhibiting activated macrophage-induced macrophage recruitment; and (3) inhibiting tumor cell migration and invasion. In vivo experimental results showed that further treatment with MnO nanoparticles after laser therapy not only inhibited the PTT-induced inflammatory response and primary tumor recurrence but also significantly reduced tumor metastasis due to the scavenging activity. These findings suggest that MnO nanoparticles hold the potential for mitigating the therapy-induced severe inflammatory response and inhibiting tumor recurrence and metastasis.


Assuntos
Neoplasias da Mama , Nanopartículas Multifuncionais , Nanopartículas , Feminino , Humanos , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Nanopartículas/química , Recidiva Local de Neoplasia , Fototerapia/métodos , Recidiva , Inflamação
17.
Biomaterials ; 283: 121393, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35349874

RESUMO

Millions of COVID-19 patients have succumbed to respiratory and systemic inflammation. Hyperstimulation of toll-like receptor (TLR) signaling is a key driver of immunopathology following infection by viruses. We found that severely ill COVID-19 patients in the Intensive Care Unit (ICU) display hallmarks of such hyper-stimulation with abundant agonists of nucleic acid-sensing TLRs present in their blood and lungs. These nucleic acid-containing Damage and Pathogen Associated Molecular Patterns (DAMPs/PAMPs) can be depleted using nucleic acid-binding microfibers to limit the patient samples' ability to hyperactivate such innate immune receptors. Single-cell RNA-sequencing revealed that CD16+ monocytes from deceased but not recovered ICU patients exhibit a TLR-tolerant phenotype and a deficient anti-viral response after ex vivo TLR stimulation. Plasma proteomics confirmed such myeloid hyperactivation and revealed DAMP/PAMP carrier consumption in deceased patients. Treatment of these COVID-19 patient samples with MnO nanoparticles effectively neutralizes TLR activation by the abundant nucleic acid-containing DAMPs/PAMPs present in their lungs and blood. Finally, MnO nanoscavenger treatment limits the ability of DAMPs/PAMPs to induce TLR tolerance in monocytes. Thus, treatment with microfiber- or nanoparticle-based DAMP/PAMP scavengers may prove useful for limiting SARS-CoV-2 induced hyperinflammation, preventing monocytic TLR tolerance, and improving outcomes in severely ill COVID-19 patients.


Assuntos
COVID-19 , Ácidos Nucleicos , Humanos , Moléculas com Motivos Associados a Patógenos , SARS-CoV-2 , Receptores Toll-Like
18.
Asian J Pharm Sci ; 16(1): 4-23, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32837565

RESUMO

SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has posed a global threat with significant human casualties and severe economic losses, there is a pressing demand to further understand the current situation and develop rational strategies to contain the drastic spread of the virus. Although there are no specific antiviral therapies that have proven effective in randomized clinical trials, currently, the rapid detection technology along with several promising therapeutics for COVID-19 have mitigated its drastic transmission. Besides, global institutions and corporations have commenced to parse out effective vaccines for the prevention of COVID-19. Herein, the present review will give exhaustive details of extensive researches concerning the drug discovery and therapeutic options for COVID-19 as well as some insightful discussions of the status of COVID-19.

19.
Adv Drug Deliv Rev ; 176: 113884, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34302897

RESUMO

Design of micro- or nanocarriers for drug delivery has primarily been focused on properties such as hydrophobicity, biodegradability, size, shape, surface charge, and toxicity, so that they can achieve optimal delivery with respect to drug loading, release kinetics, biodistribution, cellular uptake, and biocompatibility. Incorporation of stimulus-sensitive moieties into the carriers would lead to "smart" delivery systems. A further evolution would be to endow the carrier with a therapeutic function such that it no longer serves as a mere passive entity to release the drug at the target tissue but can be viewed as a therapeutic agent in itself. In this review, we will discuss recent and ongoing efforts over the past decade to design therapeutic drug carriers that confer a biological benefit, including ROS scavenging or generating, pro- or anti-inflammatory, and immuno-evasive properties, to enhance the overall therapeutic efficacy of the delivery systems.


Assuntos
Sistemas de Liberação de Medicamentos , Animais , Humanos , Espécies Reativas de Oxigênio
20.
Biomaterials ; 276: 121028, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34293701

RESUMO

microRNA-mediated direct cardiac reprogramming, directly converts fibroblasts into induced cardiomyocyte-like cells (iCMs), which holds great promise in cardiac regeneration therapy. However, effective approaches to deliver therapeutic microRNA into cardiac fibroblasts (CFs) to induce in vivo cardiac reprogramming remain to be explored. Herein, a non-viral biomimetic system to directly reprogram CFs for cardiac regeneration after myocardial injury was developed by coating FH peptide-modified neutrophil-mimicking membranes on mesoporous silicon nanoparticles (MSNs) loaded with microRNA1, 133, 208, and 499 (miR Combo). Through utilizing the natural inflammation-homing ability of neutrophil membrane protein and FH peptide's high affinity to tenascin-C (TN-C) produced by CFs, this nanoparticle could realize sequential targeting to CFs in the injured heart and precise intracellular delivery of miRCombo, which induced reprogramming resident CFs into iCMs. In a mouse model of myocardial ischemia/reperfusion injury, intravenous injection of the nanoparticles successfully delivered miRCombo into fibroblasts and led to efficient reprogramming, resulting in improved cardiac function and attenuated fibrosis. This delivery system is minimally invasive and bio-safe, providing a proof-of-concept for biomimetic and sequential targeting nanomedicine delivery system for microRNA-mediated reprogramming therapy in multiple diseases.


Assuntos
Reprogramação Celular , Nanopartículas , Animais , Fibroblastos , Camundongos , Miócitos Cardíacos , Regeneração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA